Medium-term Outcomes of Urolift (Minimum 12 Months Follow-up): Evidence From a Systematic Review

Urology

Volumn 97, Issue , 2016, Pages 20-24

  Jones, Patrick ^a   Rajkumar, G N ^b   Rai, Bhavan Prasad ^c   Aboumarzouk, Omar M ^d   Cleaveland, Paul ^a   Srirangam, Shalom J ^a   Somani, Bhaskar K ^e  

^a ROYAL BLACKBURN HOSPITAL   (United Kingdom)

^b BASINGSTOKE AND NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^c LISTER HOSPITAL   (United Kingdom)

^d Wales Deanery ^*  (United Kingdom)

^e UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMED CENTRAL; COCHRANE LIBRARY; DEVICE SAFETY; DYSURIA; EMBASE; FOLLOW UP; HEMATURIA; HUMAN; LEARNING CURVE; LOWER URINARY TRACT SYMPTOM; MALE; MEDICAL DEVICE COMPLICATION; MEDLINE; MINIMALLY INVASIVE PROCEDURE; PELVIC PAIN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATIC URETHRAL LIFT; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCIENCEDIRECT; SCOPUS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UROLOGICAL THERAPEUTIC DEVICE; ADVERSE DEVICE EFFECT; COMPLICATION; LENGTH OF STAY; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PROSTATISM; PROSTHESES AND ORTHOSES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; MALE; OPERATIVE TIME; POSTOPERATIVE COMPLICATIONS; PROSTATIC HYPERPLASIA; PROSTATISM; PROSTHESES AND IMPLANTS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84977498009     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2016.05.003     Document Type: Review

References (20)

1. 1 Loeb, S., Kettermann, A., Carter, H.B., et al. Prostate volume changes over time: results from the Baltimore Longitudinal Study of Aging. J Urol 182 (2009), 1458–1462.
2. 2 St. Sauver, J.L., Jacobson, D.J., Girman, C.J., et al. Tracking of longitudinal changes in measures of benign prostatic hyperplasia in a population based cohort. J Urol 175 (2006), 1018–1022.
3. 3 Emberton, M., Martorana, G., BPH: social impact and patient's perspective. Eur Urol Suppl 5 (2006), 991–996.
4. 4 Hashim, H., Abrahms, P., Transurethral resection of the prostate for benign prostatic obstruction: will it remain the gold standard?. Eur Urol 67 (2015), 1097–1098.
5. 5 Rassweiler, J., Teber, D., Kuntz, R., et al. Complications of transurethral resection of the prostate (TURP)—incidence, management, and prevention. Eur Urol 50 (2006), 969–979.
6. 6 Jones, P., Rai, B.P., Aboumarzouk, O.M., et al. Prostatic urethral lift vs prostate arterial embolization: novel nonablative strategies in the management of lower urinary tract symptoms secondary to benign prostate hyperplasia. Urology 87 (2016), 11–17, 10.1016/j.urology.2015.10.005.
7. 7 Dindo, D., Demartines, N., Clavien, P.A., Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240 (2004), 205–213.
8. 8 Somani, B.K., Nabi, G., Thorpe, P., et al. Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review. J Urol 179 (2008), 1844–1849.
9. 9 Martin, R.C. 2nd, Brennan, M.F., Jaques, D.P., Quality of complication reporting in the surgical literature. Ann Surg 235 (2002), 803–813.
10. 10 Woo, H., Chin, P.T., McNicholas, T.A., et al. Safety and feasibility of the prostatic urethra lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int 108 (2011), 82–88.
11. 11 Chin, P.T., Bolton, D., Jack, D., et al. Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 79 (2012), 5–11 21.
12. 12 McNicholas, T.A., Woo, H.H., Chin, P.T., et al. Minimally invasive prostatic urethral lift: surgical technique and multinational experience. Eur Urol 64 (2013), 292–299.
13. 13 Roehrborn, C.G., Gange, S.N., Shore, N.D., et al. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the LIFT study. J Urol 190 (2013), 2161–2167.
14. 14 Cantwell, A.L., Bogache, W.K., Richardson, S.F., et al. Multicentre prospective crossover study of the “prostatic urethral lift” for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. BJU Int 113 (2014), 615–622.
15. 15 Sønksen, J., Barber, N.J., Speakman, M.J., et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol 68 (2015), 643–652.
16. 16 Bozkurt, A., Karabakan, M., Keskin, E., et al. Prostatic urethral lift: a new minimally invasive treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urol Int 96 (2016), 202–206 Epub 2015 Nov 28.
17. 17 Garcia, C., Chin, P.T., Rashid, P., et al. Prostatic urethral lift: a minimally invasive treatment for benign prostatic hyperplasia. Prostate Int 3 (2015), 1–5, 10.1016/j.prnil.2015.02.002.
18. 18 NICE Medical Technology Guidance [MTG26], UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia. Available at: https://www.nice.org.uk/guidance/mtg26/resources, 2015 Accessed February 1, 2016.
19. 19 Marra, G., Sturch, P., Oderda, M., et al. Systematic review of lower urinary tract symptoms/benign prostatic hyperplasia surgical treatments on men's ejaculatory function: time for a bespoke approach?. Int J Urol 23 (2016), 22–35, 10.1111/iju.12866.
20. 20 Ray, A., Morgan, H., Wilkes, A., et al. The urolift system for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a NICE Medical Technology Guidance. Appl Health Econ Health Policy, 2016, 1–2.